These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30393114)

  • 1. Identification of nafamostat mesilate as an inhibitor of the fat mass and obesity-associated protein (FTO) demethylase activity.
    Han X; Wang N; Li J; Wang Y; Wang R; Chang J
    Chem Biol Interact; 2019 Jan; 297():80-84. PubMed ID: 30393114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Clausine E as an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity.
    Wang Y; Li J; Han X; Wang N; Song C; Wang R; Chang J
    J Mol Recognit; 2019 Oct; 32(10):e2800. PubMed ID: 31321808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Natural Compound Radicicol as a Potent FTO Inhibitor.
    Wang R; Han Z; Liu B; Zhou B; Wang N; Jiang Q; Qiao Y; Song C; Chai J; Chang J
    Mol Pharm; 2018 Sep; 15(9):4092-4098. PubMed ID: 30063141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characteristics of small-molecule inhibitors targeting
    Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
    Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.
    Sendo T; Itoh Y; Goromaru T; Sumimura T; Saito M; Aki K; Yano T; Oishi R
    Br J Pharmacol; 2003 Mar; 138(5):959-67. PubMed ID: 12642398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.
    Ookawara S; Tabei K; Sakurai T; Sakairi Y; Furuya H; Asano Y
    Eur J Clin Pharmacol; 1996; 51(2):149-51. PubMed ID: 8911880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
    Park KT; Kang DH; Choi CW; Cho M; Park SB; Kim HW; Kim DU; Chung CW; Yoon KT
    Pancreas; 2011 Nov; 40(8):1215-9. PubMed ID: 21775918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
    Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
    Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.
    Doucet JJ; Hoyt DB; Coimbra R; Schmid-Schönbein GW; Junger WG; Paul L W; Loomis WH; Hugli TE
    J Trauma; 2004 Mar; 56(3):501-10; discussion 510-1. PubMed ID: 15128119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chlorine atom on the binding between 2-phenyl-1H-benzimidazole analogues and fat mass and obesity-associated protein.
    Li J; Wang Y; Han X; Wang N; Yu W; Wang R; Chang J
    J Mol Recognit; 2019 Jun; 32(6):e2774. PubMed ID: 30575149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafamostat mesilate is an extremely potent inhibitor of human tryptase.
    Mori S; Itoh Y; Shinohata R; Sendo T; Oishi R; Nishibori M
    J Pharmacol Sci; 2003 Aug; 92(4):420-3. PubMed ID: 12939527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
    Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
    ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
    [No Abstract]   [Full Text] [Related]  

  • 14. A photo-responsive chemical modulation of m
    Lan L; Sun YJ; Liu L; Cheng L
    Chem Commun (Camb); 2021 Oct; 57(81):10548-10551. PubMed ID: 34553720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design and evaluation of novel N-phenyl-1H-indol-2-amine derivatives for fat mass and obesity-associated (FTO) protein inhibition.
    Padariya M; Kalathiya U
    Comput Biol Chem; 2016 Oct; 64():414-425. PubMed ID: 27644082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
    Yamashita Y; Ishiguro Y; Sano D; Kimura M; Fujita K; Yoshida T; Horiuchi C; Taguchi T; Matsuda H; Mikami Y; Tsukuda M
    Auris Nasus Larynx; 2007 Dec; 34(4):487-91. PubMed ID: 17337140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the Interaction between 1,3-Diazaheterocyclic Compounds and the Fat Mass and Obesity-Associated Protein by Fluorescence Spectroscopy and Molecular Modeling.
    Zhang L; Ren T; Tian X; Wang Z; Yu W; Wang R; Chang J
    J Fluoresc; 2017 Jan; 27(1):369-378. PubMed ID: 27815784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.
    Prakash M; Itoh Y; Fujiwara Y; Takahashi Y; Takada Y; Mellini P; Elboray EE; Terao M; Yamashita Y; Yamamoto C; Yamaguchi T; Kotoku M; Kitao Y; Singh R; Roy R; Obika S; Oba M; Wang DO; Suzuki T
    J Med Chem; 2021 Nov; 64(21):15810-15824. PubMed ID: 34727689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Specific
    Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
    Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
    Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
    Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.